SUBSCRIBE
SUBSCRIBE

Rezolute, Inc.

NEWS
Woman With Pipette And Test Tubes
Drug Development
Clinical Catch-Up: Moderna COVID-19 Vaccine for Kids and Much More
Although it was relatively quiet in COVID-19-related clinical trials, there was plenty of other clinical trial news. Here’s a look.
March 25, 2022
 · 
10 min read
 · 
Mark Terry
Business
BioSpace Movers & Shakers, March 12
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
March 11, 2021
 · 
7 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Drug Development
Rezolute Presents RZ358 Clinical Data-Validated Model of the Pharmacokinetics and Glycemic Response in Congenital Hyperinsulinism at Pediatric Endocrine Society 2020 Annual Meeting
June 1, 2020
 · 
6 min read
Biotech Bay
Rezolute to Present Clinical Data for RZ358, Lead Candidate in Phase 2b Trial in Congenital Hyperinsulinism at Virtual Pediatric Endocrine Society 2020 Annual Meeting
May 28, 2020
 · 
4 min read
Deals
Rezolute, Inc. Announces Updates to Clinical and Business Operations in Response to COVID-19 Pandemic
May 14, 2020
 · 
3 min read
Business
XOMA Reports Fourth Quarter and Full-Year 2019 Financial Results and Operating Highlights
March 10, 2020
 · 
12 min read
Drug Development
Rezolute Initiates Phase 2b Clinical Trial of Lead Candidate RZ358 in Congenital Hyperinsulinism
February 10, 2020
 · 
5 min read
Biotech Bay
Rezolute to Present at BIO CEO & Investor Conference 2020
January 27, 2020
 · 
2 min read
Drug Development
Rezolute, Inc. Announces Top-line Results from Phase 1 Trial Evaluating AB101 in Patients with Diabetes
December 18, 2019
 · 
3 min read
Biotech Bay
Rezolute Management to Present at 2020 Biotech Showcase Conference
December 2, 2019
 · 
2 min read
Deals
Rezolute Management to Present at 2019 BIO Investor Forum Conference
October 11, 2019
 · 
2 min read
Rezolute Enters Into Common Stock Purchase Agreement for Up to $10M With Lincoln Park Capital Fund, LLC
December 27, 2017
 · 
4 min read
Load More